Biohit Oyj CEO Semi Korpela takes sick leave
Biohit Oyj Stock Exchange Release January 5, 2017 at 1:00 pm local time (EEST) Starting from January 5, 2017 Biohit Oyj´s CEO Semi Korpela will take a sick leave of approximately one month related to pneumonia. During Semi Korpela´s sick leave, his deputy will be Biohit Oyj`s CFO Niklas Nordström. Board of Directors Additional information: Osmo Suovaniemi, Chairman of the Board of Directorstel. +358 9 773 861investor.relations@biohit.fiwww.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company.